Intramural Lombardi Grants Awarded to 14 Investigators from ACS and CCSG Funding Mechanisms
February 25, 2010
Several Lombardi researchers were recently awarded $30,000 intramural grants funded by the American Cancer Society (ACS) Young Investigator program and the Cancer Center Support Grant (CCSG) Developmental Funds.
The annual Young Investigator Awards, funded by the ACS, provide funding for the initiation of promising new projects by junior faculty members so they can obtain preliminary results. The goal is to enable them to compete successfully for national research grants.
Each year, one grant is awarded in the special interest area of psychosocial and behavioral research in underserved populations. Sherri Wallington, PhD, program director for the office of Minority Health and Health Disparities received the special interest award. Wallington’s research will test the feasibility of an HPV educational intervention with a cellular telephone and text message component.
Additional recipients of ACS grants are:
Sanjay Adhikari, PhD
Molecular Mechanism of Abasic Site (AP-site) Repair by Apurinic-Apyrimidinic Endonuclease (APE)
Mireille Bright-Gbebry, RD, MPH, PhD
Towards Cancer Prevention: A Dietary Questionnaire for West African Immigrants
Olga Timofeeva, PhD
Investigation of STAT3 Acetylation in Regulation of Gene Expression in Breast Cancer Cells
Sherrie Wallington, PhD
Testing the Feasibility of an HPV Educational Intervention with a Cellular Telephone and Text Message Component
The CCSG Developmental Funds Awards (DFA) are designed to encourage synergy among investigators, both within and across programs, to foster new collaborations. Funded by the National Cancer Institute through Lombardi’s Core Grant, the focus is on team science. The following research teams received DFA awards:
Christopher Albanese, PhD, Aykut Uren, MD, Milton Brown, PhD, MD, Jeffrey A Toretsky, MD, and Bahram Moasser, PhD (GRC & 3DT Programs)
Effects of Arsenic Trioxide or VMY-1-103, a GUMC CDK Inhibitor, on Medulloblastoma Proliferation and Apoptosis In Vitro and In Vivo
Yali Kong, PhD, and Brent Korba, PhD (3DT Program)
Development of Small Molecule Inhibitors for Hepatitis C Virus
Mary Beth Martin, PhD, Jennifer Eng-Wong, MD, MPH and Celia Byrne, PhD (BC & CBE Programs)
Role of Metalloestrogens in Breast Cancer